One of the primary areas of focus in the Koch Institute is the development of new materials systems and biomedical devices for cancer prevention, detection and treatment. These systems underpin development of new approaches for biomarker detection, imaging modalities, and targeted therapies and vaccines. Center Members are exploring a wide range of materials to achieve these goals, and employ combinatorial development approaches to facilitate the discovery of new biomaterials and nanoformulations. State-of-the-art capabilities for high resolution and surface imaging and chemical and physical analysis are key tools to enable these studies. To fully characterize new materials, establish structure-property-function relationships, and facilitate subsequent rational design, we established the Nanotechnology Materials Core in 2012. In the previous competing renewal, the Core was approved for CCSG funding as an established Shared Resource. This Core integrates a range of advanced technologies including a state-of-the-art cryo-electron microscopy (cryo-EM) imaging suite, which enables high resolution analyses of soft biomaterials and cellular ultrastructure. In the current funding period, the Core added a significant number of new capabilities and modified existing services, including: new EM sample preparation instruments; new EM and correlative light and EM imaging systems; new physical/chemical characterization capabilities; and upgrades to existing instruments. To best capitalize on these acquisitions, CCSG Developmental funds were used to support two Cryo-EM Specialists. Core service usage by Center Members has increased, from 14% at the time of the last renewal to 43% of Center Members, who account for 79% of Core service use and include investigators from all three Research Programs. Core staff has established cryo-EM workflows that are customized for Center Member research needs, and we seek continued, partial funding to support and stabilize the Research Specialists? efforts. In the upcoming period, the Nanotechnology Materials Core will continue to offer a wide range of state-of-the- art services to support Center Member research programs, and will evaluate emerging capabilities in the context of Center Member needs and interests. A primary focus will be on refining new workflows to take full advantage of newly acquired instrumentation. Other planned initiatives include: developing resources to support advanced image processing, visualization, quantitation and machine learning, and collaborating with other Cores to develop a monthly workshop series to support Center Members? access to imaging technology platforms and data analysis. This Shared Resource is essential to the success of the Koch Institute mission and provides exceptional value to the CCSG. The requested CCSG budget for Year 49 is decreased by 40.6% over the Core CCSG budget for the current period (Year 48), reflecting the increased fraction of support from user chargebacks as Core staff is moved from CCSG Developmental funds to CCSG Core funds.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts Institute of Technology
United States
Zip Code
Wong, Madeline Y; Doan, Ngoc Duc; DiChiara, Andrew S et al. (2018) A High-Throughput Assay for Collagen Secretion Suggests an Unanticipated Role for Hsp90 in Collagen Production. Biochemistry 57:2814-2827
Danai, Laura V; Babic, Ana; Rosenthal, Michael H et al. (2018) Altered exocrine function can drive adipose wasting in early pancreatic cancer. Nature 558:600-604
Dubbury, Sara J; Boutz, Paul L; Sharp, Phillip A (2018) CDK12 regulates DNA repair genes by suppressing intronic polyadenylation. Nature 564:141-145
Crowell, Laura E; Lu, Amos E; Love, Kerry R et al. (2018) On-demand manufacturing of clinical-quality biopharmaceuticals. Nat Biotechnol :
Tokatlian, Talar; Kulp, Daniel W; Mutafyan, Andrew A et al. (2018) Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes. Sci Rep 8:16527
Berger, Gilles; Grauwet, Korneel; Zhang, Hong et al. (2018) Anticancer activity of osmium(VI) nitrido complexes in patient-derived glioblastoma initiating cells and in vivo mouse models. Cancer Lett 416:138-148
Lo, Justin H; Hao, Liangliang; Muzumdar, Mandar D et al. (2018) iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer. Mol Cancer Ther 17:2377-2388
Phillips, Angela M; Doud, Michael B; Gonzalez, Luna O et al. (2018) Enhanced ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin. Elife 7:
Johnson, Hannah; White, Forest M (2018) Quantitative Analysis of Tyrosine Kinase Signaling Across Differentially Embedded Human Glioblastoma Tumors. Methods Mol Biol 1711:149-164
Tentori, Augusto M; Nagarajan, Maxwell B; Kim, Jae Jung et al. (2018) Quantitative and multiplex microRNA assays from unprocessed cells in isolated nanoliter well arrays. Lab Chip 18:2410-2424

Showing the most recent 10 out of 904 publications